Table 4 Differences in analytical sensitivity and specificity between the studied SARS-CoV-2 kits in clinical samples.
From: Commercially available SARS-CoV-2 RT-qPCR diagnostic tests need obligatory internal validation
Results | Sensitivity (%) | Specificity (%) | |||
|---|---|---|---|---|---|
Positive | Negative | Inconclusive | |||
Liferiver | 86 | 45 | 1 | 100 | 97.8 |
Vitassay | 82 | 48 | 2 | 98.8 | 100 |
TaqPath | 82 | 50 | 0 | 98.8 | 100 |
